Uttar Pradesh has attracted investment of Rs 2,845 crore in the fast growing pharmaceutical sector in the last three years.
The investment, netted via the single window portal of UP’s Nivest Mitra, pertains to manufacturing units, blood centers and drug retail establishments.
“The Yogi Adityanath government is witnessing a remarkable transformation in the state’s pharmaceutical sector. The single window portal has emerged a game-changer, significantly easing the process of doing business for pharma entrepreneurs and investors,” a senior official said.
So far, the portal has facilitated the issuance of over 171,000 licenses, propelling unprecedented growth in the industry.
Complementing this digital push is the implementation of the UP Pharmaceutical and Medical Device Policy 2023, which, in coordination with the Central Drugs Standard Control Organisation (CDSCO), has enhanced business ease and transparency.
These initiatives are not only drawing significant investment into the pharma industry but also opening up new avenues for employment.
Between 2022–23 and 2024–25, around 167 manufacturing units were set up, creating 3,340 jobs.
In the same period, 195 blood centers and 32,475 medicine retail outlets were also established, which created approximately 1,365 and 64,995 jobs respectively.
The Pharmaceutical and Medical Device Policy 2023 has further strengthened investor confidence.
The policy offers several incentives, including stamp duty exemption, encouraging new investments and expansion of existing businesses.
Additionally, the state government, in coordination with the CDSCO, implemented the Online National Drug Licensing System (ONDLS) portal.
This portal plays a key role in issuing licenses related to medicines, cosmetics and blood centers.
This initiative is not only helping the UP pharma industry reach new heights but also contributing significantly to economic growth and job creation.